HY-133 is under clinical development by HyPharm and currently in Phase I for Staphylococcal Infections. According to GlobalData, Phase I drugs for Staphylococcal Infections have a 63% phase transition ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Nurse loses leg after cutting foot, contracting bacterial infection while on Florida vacation SURPRISE, Ariz. ( KPHO /Gray News) – A nurse in Arizona is adjusting to his new normal after losing his ...